Evidence map›Paper›PMID 35623390›Full record

ArticleThe Journal of biological chemistry2022

Cardiac ventricular myosin and slow skeletal myosin exhibit dissimilar chemomechanical properties despite bearing the same myosin heavy chain isoform.

Tianbang Wang, Emrulla Spahiu, Jennifer Osten, Florentine Behrens, Fabius Grünhagen, Tim Scholz, Theresia Kraft, Arnab Nayak, Mamta Amrute-Nayak

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cardiac Troponin ActivatorJournal of medicinal chemistry · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tianbang WangInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Emrulla SpahiuInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Jennifer OstenInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Florentine BehrensInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Fabius GrünhagenInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Tim ScholzInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Theresia KraftInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany.
Arnab NayakInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany. Electronic address: Nayak.arnab@mh-hannover.de.
Mamta Amrute-NayakInstitute of Molecular and Cell Physiology, Hannover Medical School, Hannover, Germany. Electronic address: amrute.mamta@mh-hannover.de.
Medizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The myosin II motors are ATP-powered force-generating machines driving cardiac and muscle contraction. Myosin II heavy chain isoform-beta (β-MyHC) is primarily expressed in the ventricular myocardium and in slow-twitch muscle fibers, such as M. soleus. M. soleus-derived myosin II (SolM-II) is often used as an alternative to the ventricular β-cardiac myosin (βM-II); however, the direct assessment of biochemical and mechanical features of the native myosins is limited. By employing optical trapping, we examined the mechanochemical properties of native myosins isolated from the rabbit heart ventricle and soleus muscles at the single-molecule level. We found purified motors from the two tissue sources, despite expressing the same MyHC isoform, displayed distinct motile and ATPase kinetic properties. We demonstrate βM-II was approximately threefold faster in the actin filament-gliding assay than SolM-II. The maximum actomyosin (AM) detachment rate derived in single-molecule assays was also approximately threefold higher in βM-II, while the power stroke size and stiffness of the "AM rigor" crossbridge for both myosins were comparable. Our analysis revealed a higher AM detachment rate for βM-II, corresponding to the enhanced ADP release rates from the crossbridge, likely responsible for the observed differences in the motility driven by these myosins. Finally, we observed a distinct myosin light chain 1 isoform (MLC1sa) that associates with SolM-II, which might contribute to the observed kinetics differences between βM-II and SolM-II. These results have important implications for the choice of tissue sources and justify prerequisites for the correct myosin heavy and light chains to study cardiomyopathies.

Indexed as

Cardiac MyosinsMyosin Heavy ChainsAnimalsHeart VentriclesMyosinsMyosin Type IIProtein IsoformsRabbitsVentricular MyosinsCardiac MyosinsMyosin Heavy ChainsMyosinsMyosin Type IIProtein IsoformsVentricular Myosinsactomyosincardiac ventricular myosinoptical trappingsingle-molecule studiesskeletal myosin

Identifiers

PMID35623390
PMCPMC9243179
OpenAlexW4281382617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.